Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma

NCT07067905 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Clear Cell Renal Cell Carcinoma and Glioblastoma

Interventions

DRUG: 68Ga-XT771

Sponsor

Chinese PLA General Hospital

Collaborators

[object Object]